The Future is here & now. The Therapeutic development has two hearts and one soul.

Slides:

Advertisements

Similar presentations

Renal Replacement Therapy Options for Children

Advertisements

CRRT Continue Renal Replacement Therapy

Dialysis in the Critically Ill

Continuous Renal Replacement Therapy

Pediatric CRRT: Terminology and Physiology

Lynda and “Abyle” products

Pediatric Septic Shock

CVVH vs CVVHD Does it Matter?

ABYLCAP CARBON DIOXIDE REMOVAL ECCO2R

Dialysis in AMU Dr Mary Rogerson, Nephrologist, SGH.

MANAGEMENT OF CONTINUOUS HEMODIALYSIS

Continuous Renal Replacement Therapy. Why continuous Therapies? Continuous therapies closely mimic the GFR of native kidneys Large amounts of fluid.

ECMO in CRRT – What are the Data?

Intensive care conference: management of acid-base disorders with CRRT International Society of Nephrology 主講人 : R2 顏介立.

Acute kidney injury R3 李岳庭 / F1 王奕淳 / VS 林景坤 Brenner and Rector's The Kidney, 8th ed P 高雄長庚腎臟科 Journal reading.

RENAL REPLACEMENT THERAPY

Therapeutic Plasma Exchange for Myasthenia Gravis Clifford Blieden, MD Houston Methodist Hospital Department of Pathology and Genomic Medicine, Division.

Pharmacotherapy in the Elderly Judy Wong

Lynda and “Abyle” products. Blood pump Moves blood in all the therapies. In CRRT the blood flow is between 0.30 and 450 ml/min. In CRRT the blood flow.

Pediatric CRRT: The Prescription

Continuous Renal Replacement Therapy -CRRT

Specific weight Size Plasma1, μm Platelets1, μm Lymphocytes1, μm Monocytes1, μm Eosinophils1,

What is a National Health Priority Area?  National Health Priority Areas (NHPAs) are diseases and conditions chosen for focused attention at a national.

How Technological Developments make better Treatment a Reality

Pediatric CRRT: The Prescription Stuart L. Goldstein, MD Associate Professor of Pediatrics Baylor College of Medicine.

Experiences with plasmapheresis in our pediatric dialysis unit L. Koster-Kamphuis, E. Cornelissen, E. Levtchenko, N. van de Kar Dept. of Pediatric Nephrology.

Tomáš Zaoral1, Michal Hladík1, Jana Zapletalová2 1Pediatric intensive care unit, Department of Pediatrics,Faculty of Medicine, University Hospital Ostrava.

Unit 8: Immune & Lymphatic System 4d. Examine various conditions that change normal body functions (e.g. tissue rejection, allergies, injury, diseases.

Renal Replacement Therapy in Intensive Care Units.

Is There a Rationale To Use CRRT For Treating Sepsis? James D. Fortenberry MD, FCCM, FAAP Pediatrician in Chief Children’s Healthcare of Atlanta Professor.

Principles of Immunology Autoimmunity 4/25/06. Organs Specific Autoimmune Diseases  Hashimoto’s thyroiditis DTH like response to thyroid Ags Ab to thyroglobulin.

University of Pittsburgh

Multiorgan failure, nutrition and PCRRT Bernhard Frey Dep. of Intensive Care and Neonatology University Children‘s Hospital Zürich 4th International Conference.

Common Terminology Used and Physiology in CRRT Jordan M. Symons, MD University of Washington School of Medicine Seattle Children’s Hospital Seattle, WA.

Haemofiltration for sepsis: burial or resurrection?

Results Methods Abstract Number 69 Objectives 1.Nephrol Dial Transplant (2011) 26: 537–543 2.J Support Oncol 2011;9:149–155 3.N Engl J Med. 2009; 361:1627–1638.

DR. HAYAM HEBAH ASSOCIATE PROFESSOR OF INTERNAL MEDICINE AL MAAREFA COLLEGE DIALYSIS.

Continuous Renal Replacement Therapy Developed by: Critical Care and Hemodialysis Educators, February 2009 King Faisal Specialist Hospital and Research.

Citrate Continuous Renal Replacement Therapy: Which Protocol? Standard Protocol 1 (SP1) Indication: First hours of therapy Effluent dose target:

Retrospective Monocentric 10-Year Analysis Of Sepsis-Associated Acute Kidney Injury: Impact On Outcome, Dialysis Dose And Residual Renal Function 1 Vincenzo.

Role of CRRT in Sepsis Dr Apoorva Jain Agra.

CRRT TERMINOLOGY Stefano Picca, MD

Adequacy of RRT in the Critically Ill: Membrane and Filter related factors Claudio Ronco, MD Department of Nephrology, St. Bortolo Hospital, International.

Acute Kidney Injury. 100,000 deaths are year are associated with acute kidney injury. (NCEPOD 2009)

CONTINUOUS RENAL REPLACEMENT THERAPY

Continuous renal replacement therapy

An AKI project for critically ill cancer patients

University of Alabama at Birmingham

Associate professor of Internal Medicine

CRRT (Continuous Renal Replacement Therapy)

When to start CRRT during ECMO?

Shiraz Medical University

Single-Pass Albumin Dialysis During Continuous Renal Replacement Therapy for Management of Liver Failure Nathan Beins1, MD ; Brooke English2, RN ; Marita.

Devices use for Neonatal AKI

Therapeutic Drug Monitoring of Levofloxacin

Motor Fluctuations in Parkinson Disease: Options and Strategies

OUTCOMES OF REGIONAL CITRATE ANTICOAGULATION (RCA) IN PEDIARTIC CONTINUOUS RENAL REPLACEMENT THERAPY (pCRRT) IN A SINGLE CENTER Issa Alhamoud, Diane Gollhofer,

Objectives Early initiation of continuous renal replacement therapy

What are we trying to dialyse?

Andrew Durward St Thomas NHS Foundation Trust Orlando 2017 CRRT IN AKI.

Pediatric CRRT Terminology

Infections in Surgical Patients: Intensive Care Unit

Aquarius Programming Guide:

Basics of CRRT: Terminology

Supplementary Figure 1: Forest plot pooling trials of RRT dose

SCUF Slow Continuous Ultrafiltration

Composite of complications including cardiovascular (CV): acute myocardial infarction, cardiac arrhythmia requiring medical treatment and heart failure;

Case 20 kg child with sepsis and oliguria on norepinephrine with a BP of 95/45 Vent at 70% FIO2 and a PEEP of 8 FO at 15% K of 6 meq/dl and a BUN of 100.

New Models of Care in Idiopathic Pulmonary Fibrosis

RCA in continuous RRT: basic principles

Presentation transcript:

the Future is here & now

The Therapeutic development has two hearts and one soul

for critical care staff The simplicity of using one single system for the widest variety of treatments The serenity of automated and simple management of complex treatments 24h/24h. The reduction and optimization of the number and time of the operation

for Clinicians A big and important therapeutic choice An advanced and targeted personalization capability Complete control of the therapeutic process

Critical Care Strategy SEPSIS MOF Multi-organ failure ALI SIRS Liver Failure AKI HYPERCHOLESTEROLEMIA DEGENERATIVE MACULOPATHIES DIABETIC FOOT RHEUMATOID ARTHRITIS MYASTHENIA GRAVIS GUILLAIN-BARRÈ SYNDROME GLOMERULONEPHRITIS ARDS many diseases in ONE equipment RRT: SCUF CVVH IHF/HVHF CVVHD IHD/SLED CVVHDF IHDF CPFA CASCADE PEX ABYLCAP ABYLCAP HD Specific and effective therapies

RRT: SCUF CVVH IHF/HVHF CVVHD IHD/SLED CVVHDF IHDF CPFA CASCADE PEX ABYLCAP ABYLCAP HD The Amplya Therapies Specific Sorbents COMPLETENESS

Hemofilter Plasmafilter Citrate CaCl 10% Post dilution Uf Mediasorb CPFA with Citrate COMPLETENESS

COMPACT study results In-hospital Intensive Care Mortality controls Tertiles CPFA dose (L/Kg) Mortality rate in-hospital and in Intensive Care units for CPFA dose in 3 days of treatment The study explain that if we perform the CPFA with right dose of plasma, the mortality change from. 55,2% Vs 25,8% Relative Risk= 46% Personalized CPFA management with controlled servo-assisted flow AUTOMATION

RRT: SCUF CVVH IHF/HVHF CVVHD IHD/SLED CVVHDF IHDF CPFA CASCADE PEX ABYLCAP ABYLCAP HD The Amplya Therapies COMPLETENESS

CASCADE FILTRATION PLASMAFILTRO PLASMA For the removal of : CIC (Circulating Immune Complexes) IgM IgG Triglycerides Lipoproteins In case of: Hypercholesterolemia Degenerative maculopathies Diabetic foot Rheumatoid arthritis Myasthenia Gravis Guillain-Barrè Syndrome.

CASCADE Rinsing LIQUIDO DI LAVAGGIO PLASMAFILTRO

RRT: SCUF CVVH IHF/HVHF CVVHD IHD/SLED CVVHDF IHDF CPFA CASCADE PEX ABYLCAP ABYLCAP HD The Amplya Therapies COMPLETENESS

Uf O2 CO2 HD Dialysate flow

Multiorgan Dysfunction: many medical devices?